Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enfusion (ENFN)
NYSE:ENFN
Enfusion (ENFN) Stock Price & Analysis
21 Followers
ENFN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.52 - $11.56
Previous Close$8.58
Volume238.13K
Average Volume (3M)349.59K
Market Cap
$1.10B
Enterprise Value$1.10B
Total Cash (Recent Filing)$35.60M
Total Debt (Recent Filing)$15.44M
Price to Earnings (P/E)424.8
Beta1.12
Next Earnings
Aug 06, 2024EPS Estimate
$0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding128,110,210
10 Day Avg. Volume371,625
30 Day Avg. Volume349,594
Standard Deviation0.17
R-Squared0.09
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)19.86
Price to Sales (P/S)4.38
Price to Cash Flow (P/CF)40.50
P/FCF Ratio62.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.55
Enterprise Value/Gross Profit6.33
Enterprise Value/Ebitda83.93
Forecast
1Y Price Target
$10.00Price Target Upside14.03% Upside
Rating ConsensusHold
Number of Analyst Covering4
Enfusion News
PremiumCompany Announcements
Enfusion’s Upcoming Investor Day and Information Disclosure
Bulls Say, Bears Say
Bulls Say
Financial PerformanceEnfusion reported first-quarter results, with total revenue and ARR growth of 17% and 14%, respectively, both ahead of Street expectations attributable to momentum across the company’s cross-sell and international sales motions as well as continued traction upstream to traditional asset managers.
Market PositionEarly traction upmarket with larger asset managers is viewed as key for multiple re-rating.
Product DevelopmentAccelerating product velocity is driving faster-than-expected increases in pipelines.
Bears Say
Client GrowthNet new clients were only +3 (33 new less 30 churned), and commentary on higher churn and downgrades could raise concerns.
CompetitionRisks to consider include competition among large, well-capitalized vendors, pace of asset management cloud adoption, and execution risk.
EBITDA60% of the EBITDA beat was from one-time savings, leading to unchanged 2024 adj EBITDA guide.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ENFN FAQ
What was Enfusion’s price range in the past 12 months?
Enfusion lowest stock price was $7.52 and its highest was $11.56 in the past 12 months.
What is Enfusion’s market cap?
Currently, no data Available
When is Enfusion’s upcoming earnings report date?
Enfusion’s upcoming earnings report date is Aug 06, 2024 which is in 31 days.
How were Enfusion’s earnings last quarter?
Enfusion released its earnings results on May 09, 2024. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.036 by $0.024.
Is Enfusion overvalued?
According to Wall Street analysts Enfusion’s price is currently Undervalued.
Does Enfusion pay dividends?
Enfusion does not currently pay dividends.
What is Enfusion’s EPS estimate?
Enfusion’s EPS estimate is $0.06.
How many shares outstanding does Enfusion have?
Enfusion has 91,911,446 shares outstanding.
What happened to Enfusion’s price movement after its last earnings report?
Enfusion reported an EPS of $0.06 in its last earnings report, beating expectations of $0.036. Following the earnings report the stock price went down -5.22%.
Which hedge fund is a major shareholder of Enfusion?
Among the largest hedge funds holding Enfusion’s share is Gilder Gagnon Howe & Co LLC.. It holds Enfusion’s shares valued at 508K.
---
Enfusion Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$10.00 (14.03% Upside)
$10.00 (14.03% Upside)
Blogger Sentiment
Bullish
ENFN Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 22.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $622.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.84%
12-Months-Change
Fundamentals
Return on Equity
4.20%
Trailing 12-Months
Asset Growth
-8.67%
Trailing 12-Months
Company Description
Enfusion
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute better-informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth.
---
ENFN Company Deck
---
ENFN Earnings Call
Q1 2024
0:00 / 0:00
---
ENFN Stock 12 Month Forecast
Average Price Target
$10.00
▲(14.03% Upside)
Technical Analysis
Best Analysts Covering ENFN
1 Year
1 Year Success Rate
4/6 ratings generated profit
1 Year Average Return
+0.20%
reiterated a sell rating 2 months ago
Copying Koji Ikeda's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +0.20% per trade.
---